Not Yet Recruiting
A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System
NCT04179045
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +5 more
- Locations
-
- Beijing Anzhen Hospital Capital Medical University Beijing, Beijing Municipality, China
- BeijingChao-YangHospital Beijing, Beijing Municipality, China
- Nanfang Hospital Guangzhou, Guangdong, China
- Taida International Cardioascular Hospital Tianjin, Tianjin Municipality, China